Advertisement
The Medicine Maker / Issues / 2026 / Articles / March / AstraZeneca Deepens China Cell Therapy Push
Advertisement

Recommended

Advertisement

Related Content

This Week’s CGT News: Eli Lilly’s Verve takeover, and more
Industry News
This Week’s CGT News: Eli Lilly’s Verve takeover, and more

June 24, 2025

3 min read

Our latest news roundup reports on Eli Lilly’s Verve takeover, novel CRISPR delivery research, a growing interest in CD5-based immunotherapy, and more

This Week’s Industry News, RFK Jr. criticizes Gavi, Trump Pulls Federal Subscriptions, and More
Industry News
This Week’s Industry News, RFK Jr. criticizes Gavi, Trump Pulls Federal Subscriptions, and More

July 1, 2025

4 min read

Our latest news roundup reports on thimerosal elimination, subscription termination, depression alleviation, and more

This Week’s CGT News: CRISPR/Cas9 improves ASOs efficacy, and more
Cell & Gene Research News Regulation & Standards
This Week’s CGT News: CRISPR/Cas9 improves ASOs efficacy, and more

July 2, 2025

3 min read

Our latest news roundup reports on how CRISPR/Cas9 improves ASOs efficacy, Abbvie’s latest acquisition, further sickle cell disease research, and more

Our latest biopharma news roundup reports on imlifidase for improved kidney transplant survival, and more
Bioprocessing Industry News
Our latest biopharma news roundup reports on imlifidase for improved kidney transplant survival, the FDA’s Gamifant approval, AI-basd antibody discovery, and more

July 2, 2025

2 min read

Advertisement